Patents by Inventor Mi Young Cha

Mi Young Cha has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL AMIDE DERIVATIVE FOR INHIBITING THE GROWTH OF CANCER CELLS
    Publication number: 20100179120
    Abstract: The present invention provides a novel amide derivative and a pharmaceutically acceptable salt thereof which selectively and effectively inhibits the growth of cancer cells induced by the overexpression of an epidermal growth factor receptor and also prevents the development of drug resistance caused by the mutation of EGFR tyrosine kinase, and a pharmaceutical composition comprising same as an active ingredient.
    Type: Application
    Filed: June 5, 2008
    Publication date: July 15, 2010
    Applicant: HANMI PHARM. CO., LTD.
    Inventors: Kwang-Ok Lee, Mi Young Cha, Mi Ra Kim, Young Hee Jung, Chang Gon Lee, Se Young Kim, Keukchan Bang, Bum Woo Park, Bo Im Choi, Yun Jung Chae, Mi Young Ko, Han Kyong Kim, Young-Gil Ahn, Maeng Sup Kim, Gwan Sun Lee
  • P-glycoprotein inhibitor, method for preparing the same and pharmaceutical composition comprising the same
    Patent number: 7625926
    Abstract: The bioavailability of an anticancer agent is enhanced when the anticancer agent is administered together with a pharmaceutical composition comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: October 6, 2004
    Date of Patent: December 1, 2009
    Assignee: Hanmi Pharm. Co., Ltd
    Inventors: Keuk Chan Bang, Mi Young Cha, Young Gil Ahn, Young Jin Ham, Maeng Sup Kim, Gwan Sun Lee
  • Isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
    Patent number: 6723724
    Abstract: The present invention relates to isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptors represented by the following formula (1), and its preparation method through reductive amination reaction in the presence of reducing agent, wherein R1, R2, X and n are the same as defined in the specification.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: April 20, 2004
    Assignees: Korea Institute of Science and Technology, Korea Research Institute of Chemical Technology, Korea Advanced Institute of Science and Technology
    Inventors: Hun Yeong Koh, Kyung Il Choi, Yong Seo Cho, Ae Nim Pae, Kyung Ho Kang, Mi Young Cha, Jae Yang Kong, Dae Young Jeong, Hee-Yoon Lee
  • Novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptor, and preparation thereof
    Publication number: 20020119983
    Abstract: The present invention relates to a novel isoxazolylalkylpiperazine derivatives having selective biological activity at dopamine D3 or D4 receptors represented by the following formula (1), and its preparation method through reductive amination reaction in the presence of reducing agent, 1
    Type: Application
    Filed: April 23, 2001
    Publication date: August 29, 2002
    Inventors: Hun Yeong Koh, Kyung II Choi, Yong Seo Cho, Ae Nim Pae, Kyung Ho Kang, Mi Young Cha, Jae Yang Kong, Dae Young Jeong, Hee-Yoon Lee